How to Find PhD Supervisors in Biotechnology (and Get Funded)

Biotech is the one major PhD field where "find a supervisor before you apply" isn't quite the right frame, most programs admit you first and let you choose a lab through rotations afterward. But funding is where the field gets genuinely field-specific: the standard NIH mechanisms that pay for biomedical training are citizenship-restricted, and if you're an international applicant, understanding exactly how the money actually reaches you changes how you should read a program's funding page.

Most biotech PhDs admit you first, then rotate you through labs

Unlike computer science or economics, where you're typically admitted directly into a named advisor's group, most US biomedical and bioengineering PhD programs run an umbrella admissions model: you're admitted to the program broadly, then complete two to four lab rotations, commonly eight to twelve weeks each, before committing to a thesis advisor. Stanford Bioengineering runs three rotations before you choose a PI. University at Buffalo's Biomedical Sciences program allows up to six rotations across the fall and spring terms. This changes what a pre-application email to a professor is actually for: it's not securing an admission decision the way it might be in a rotation-free field, it's building the kind of specific, informed application that makes your program-level admission more competitive, and giving yourself a running start on which labs are worth rotating through once you arrive.

Worth watching, though: this norm isn't universal or permanent. Washington University's McKelvey School of Engineering ended lab rotations entirely for its 2026 admissions cycle, moving to a direct-match model where students are paired with one faculty advisor before they arrive, with reporting noting that rotations "tend to survive where external fellowship funding makes them financially viable." That's a real signal that funding pressure, not just pedagogy, shapes whether a given program keeps rotations at all, so check a specific program's current admissions page rather than assuming every biotech PhD works the same way.

T32 and F31 funding: real, well-paid, and closed to international students

NIH's T32 institutional training grants and F31 individual predoctoral fellowships are the backbone of a lot of US biomedical PhD funding, and both come with a hard citizenship requirement: the trainee must be a US citizen, non-citizen national, or lawful permanent resident at the time of the award. Temporary visa holders don't qualify, full stop, it isn't a matter of a stronger application overcoming the restriction. NSF's Graduate Research Fellowship Program carries the same US citizen or permanent resident requirement for biotech-adjacent fields. Unlike public health, where the NIH's Fogarty International Center runs programs specifically aimed at researchers from low- and middle-income countries, there's no clearly equivalent LMIC-friendly mechanism built for general biotech or biomedical bench science. If you're applying from outside the US, this pair of restrictions is the single most important funding fact to understand early.

How international students actually get funded: the R01, not the fellowship

The realistic funding route for an international biotech PhD applicant is a professor's own NIH research grant, typically an R01 or R21, which carries no citizenship restriction for the graduate students it supports, unlike the T32 and F31 mechanisms built specifically for training. On top of that, a number of biomedical PhD programs explicitly guarantee full funding to every admitted student regardless of citizenship: University at Buffalo's Biomedical Sciences program, the University of Florida's Biomedical Sciences program at roughly $37,000 a year, Johns Hopkins' Biomedical Engineering program, and Penn's Biomedical Graduate Studies program at roughly $49,000 a year as of Fall 2026. These guarantees are funded through a mix of grant-supported RA positions and the program's own institutional funds, which is exactly why the professor-identification step still matters under a rotation system: a program that guarantees your funding still needs enough labs with live R01 grants for that guarantee, and the rotation system built around it, to actually work.

The UK's BBSRC route runs its own two-rotation model

In the UK, biotech and bioscience PhD funding runs mainly through BBSRC-funded Doctoral Training Partnerships (DTPs), and several of the major ones run their own rotation structure, typically two rotation projects rather than the three or more common in the US: the LIDo DTP runs two four-month rotations, Oxford's Interdisciplinary Bioscience DTP runs two twelve-week rotations, and Cambridge's Biosciences DTP runs two rotations, one of which is usually the project you originally applied for. That makes BBSRC DTPs a genuine outlier among UK PhDs, where the direct-supervisor-match model is otherwise the norm across most fields. UKRI's minimum PhD stipend is £20,780 a year for 2025/26, rising to £21,805 from October 2026, with an additional London weighting of roughly £2,000 where relevant.

A tighter funding picture in 2025-2026

Biotech's federal funding backdrop has genuinely shifted recently, and it's worth knowing about before you apply rather than discovering it after. The FY2026 US budget proposal cuts NIH's core grant-awarding budget by roughly 43%, and reporting through 2025 documented NIH terminating a wave of already-awarded F31 fellowships mid-cycle. Several institutions responded by shrinking incoming cohorts, Penn's Perelman School of Medicine cut its Fall 2025 PhD admissions by roughly 35%, and multiple programs paused or reduced admissions in February 2025 amid funding-freeze uncertainty. None of this means biotech PhD funding has disappeared, R01-funded labs and program-wide guarantees are still real and still active, but it does mean confirming a specific professor's current, active funding matters more now than it might have a few years ago, rather than relying on an older reputation for being well-funded.

Checking whether a lab is actually funded right now

NIH RePORTER, a free public database at report.nih.gov, lists NIH grant awards searchable by principal investigator, institution, and funding mechanism, updated weekly and defaulting to currently active projects, making it the most direct way to confirm a specific professor holds a live R01, R21, or T32 award right now rather than relying on an old lab page. Pair it with PubMed, the field's standard literature database, to confirm they're actively publishing. Checking both together, funding and output, gives a genuinely current picture, and it's a five-minute check worth doing before you invest time researching a lab in depth or writing them a specific email.

A practical search order

• Identify professors actively publishing in your subfield on PubMed, then cross-check NIH RePORTER to confirm they currently hold active grant funding, an R01 or R21 for international applicants specifically.
• Confirm whether your target program runs a rotation model and how many rotations, since this changes how much weight your application should put on naming one specific lab versus showing broad research fit.
• If you're a US citizen or permanent resident, separately check your eligibility for T32 or F31 funding through the program, since these can offer better terms than a standard RA position where available.
• Email a specific professor whose recent work genuinely interests you, referencing that work directly, even under a rotation system, since it strengthens your application and gives you a head start on which labs to prioritize once you arrive.

GradScoutFunding is built for that first step: it searches professors by field and country, confirms they're actively publishing, and drafts a personalized first email grounded in their real recent paper for you to review and send yourself, it never sends anything automatically. The free tier gives 2 credits with no card required, and paid credit packs are one-time purchases that never expire.

Common questions